Literature DB >> 19285865

The m.3244G>A mutation in mtDNA is another cause of progressive external ophthalmoplegia.

Evangelia Sotiriou1, Jorida Coku, Kurenai Tanji, Hua-bin Huang, Michio Hirano, Salvatore DiMauro.   

Abstract

We sequenced all mitochondrial tRNA genes in a 61-year-old man with chronic progressive external ophthalmoplegia and mitochondrial myopathy but without mtDNA rearrangements, and identified a heteroplasmic m.3244G>A mutation in the tRNA(Leu(UUR)) gene. This mutation had been previously associated with the MELAS phenotype, but not described in any detail. The mutation load in muscle was 84% and COX-negative fibers harbored greater levels of mutant genomes than COX-positive fibers. The m.3244G>A mutation affects a highly conserved nucleotide in the dihydrouridine loop and has been associated with a wobble modification deficiency of the mutant tRNA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19285865      PMCID: PMC2699630          DOI: 10.1016/j.nmd.2009.01.014

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  10 in total

1.  Mitochondrial DNA sequence variation in single cells from leukemia patients.

Authors:  Yong-Gang Yao; Yoji Ogasawara; Sachiko Kajigaya; Jeffrey J Molldrem; Roberto P Falcão; Maria-Carolina Pintão; J Philip McCoy; Edgar Gil Rizzatti; Neal S Young
Journal:  Blood       Date:  2006-08-31       Impact factor: 22.113

Review 2.  Mitochondrial DNA and disease.

Authors:  Salvatore Dimauro; Guido Davidzon
Journal:  Ann Med       Date:  2005       Impact factor: 4.709

3.  Clinical and molecular features of encephalomyopathy due to the A3302G mutation in the mitochondrial tRNA(Leu(UUR)) gene.

Authors:  Wendy M Hutchison; Dominic Thyagarajan; Joanna Poulton; David R Marchington; Denise M Kirby; Shehnaaz S M Manji; Hans-Henrik M Dahl
Journal:  Arch Neurol       Date:  2005-12

Review 4.  Mitochondrial DNA mutations and pathogenesis.

Authors:  E A Schon; E Bonilla; S DiMauro
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

Review 5.  Human mitochondrial DNA diseases.

Authors:  T Pulkes; M G Hanna
Journal:  Adv Drug Deliv Rev       Date:  2001-07-02       Impact factor: 15.470

6.  Defect in modification at the anticodon wobble nucleotide of mitochondrial tRNA(Lys) with the MERRF encephalomyopathy pathogenic mutation.

Authors:  T Yasukawa; T Suzuki; N Ishii; T Ueda; S Ohta; K Watanabe
Journal:  FEBS Lett       Date:  2000-02-11       Impact factor: 4.124

7.  Specific correlation between the wobble modification deficiency in mutant tRNAs and the clinical features of a human mitochondrial disease.

Authors:  Yohei Kirino; Yu-Ichi Goto; Yolanda Campos; Joaquin Arenas; Tsutomu Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-03       Impact factor: 11.205

8.  A novel mitochondrial tRNA(Leu(UUR)) mutation in a patient with features of MERRF and Kearns-Sayre syndrome.

Authors:  Yutaka Nishigaki; Saba Tadesse; Eduardo Bonilla; Dikoma Shungu; Stephen Hersh; Bronya J B Keats; Charles I Berlin; Morton F Goldberg; Jerry Vockley; Salvatore DiMauro; Michio Hirano
Journal:  Neuromuscul Disord       Date:  2003-05       Impact factor: 4.296

9.  Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA.

Authors:  C T Moraes; F Ciacci; G Silvestri; S Shanske; M Sciacco; M Hirano; E A Schon; E Bonilla; S DiMauro
Journal:  Neuromuscul Disord       Date:  1993-01       Impact factor: 4.296

10.  Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications.

Authors:  J S Carew; Y Zhou; M Albitar; J D Carew; M J Keating; Peng Huang
Journal:  Leukemia       Date:  2003-08       Impact factor: 11.528

  10 in total
  2 in total

Review 1.  Molecular and neurological features of MELAS syndrome in paediatric patients: A case series and review of the literature.

Authors:  Lydia M Seed; Andrew Dean; Deepa Krishnakumar; Poe Phyu; Rita Horvath; Pooja Devi Harijan
Journal:  Mol Genet Genomic Med       Date:  2022-04-26       Impact factor: 2.473

2.  Extensive screening system using suspension array technology to detect mitochondrial DNA point mutations.

Authors:  Yutaka Nishigaki; Hitomi Ueno; Jorida Coku; Yasutoshi Koga; Tatsuya Fujii; Ko Sahashi; Kazutoshi Nakano; Makoto Yoneda; Michiko Nonaka; Linya Tang; Chia-Wei Liou; Veronique Paquis-Flucklinger; Yasuo Harigaya; Tohru Ibi; Yu-ichi Goto; Hiroko Hosoya; Salvatore DiMauro; Michio Hirano; Masashi Tanaka
Journal:  Mitochondrion       Date:  2010-01-11       Impact factor: 4.160

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.